Thomas Lynch, Endpoints News
Thomas Lynch finds a new home as leader of the Fred Hutch — and he’s staying focused on cancer breakthroughs
Thomas Lynch didn’t last long in the pressure-packed R&D world of Big Pharma R&D, but that doesn’t mean he’s out of the spotlight. Lynch, former head of research at Bristol-Myers Squibb, will now vault to the top of the Fred Hutch in Seattle, one of the most notable research institutions in the world.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.